CT
IONS icon

Colonial Trust’s Ionis Pharmaceuticals IONS Stock Holding History

Colonial Trust’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-120
Closed -$6.06K – 998
2023
Q4 		$6.06K Hold
120
– – ﹤0.01% 778
2023
Q3 		$4.85K Hold
120
– – ﹤0.01% 792
2023
Q2 		$4.93K Buy
120
+38
+46% +$1.46K ﹤0.01% 784
2023
Q1 		$2.86K Hold
82
– – ﹤0.01% 816
2022
Q4 		$3.06K Buy
+82
New +$3.45K ﹤0.01% 822

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Colonial Trust's IONS Position: Q1 2024 in Review

Colonial Trust sold out of Ionis Pharmaceuticals (IONS) in Q1 2024, closing a stake of 120 shares — an estimated $6.06K sold.

Colonial Trust first reported a position in IONS in Q4 2022 and held it in 5 quarters. The position peaked at $6.06K in Q4 2023. 361 funds tracked by Wall St. Rank hold IONS as of Q1 2024.

  • Colonial Trust reported no remaining Ionis Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Colonial Trust sold 120 Ionis Pharmaceuticals shares in Q1 2024, an estimated $6.06K.
  • Colonial Trust first reported a position in Ionis Pharmaceuticals in Q4 2022 and held it in 5 quarters.
  • Colonial Trust's Ionis Pharmaceuticals position peaked at $6.06K in Q4 2023.
  • 361 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2024.

Based on Colonial Trust's 13F filing for Q1 2024, filed 14 May 2024.